IMBED BIO RECRUITS JEFFREY DALSIN TO LEAD PRODUCT DEVELOPMENT
Madison, WI, October 1, 2016 – Imbed Biosciences, a developer of advanced biomaterials and wound care devices, announced today that Jeffrey Dalsin, Ph.D. will join the Imbed leadership team as Vice President of Product Development. Dr. Dalsin will lead development of Imbed’s flagship product Microlyte® Ag wound dressings and product pipeline under quality control for new medical applications. He brings more than 15 years’ experience developing novel biomaterials and medical devices. Based on his doctoral work, Jeff helped cofound Nerites Corporation, a start-up that commercialized an innovative surgical adhesive and served as Director of Product Development. In that role, Jeff wore many hats and gained broad start-up operational experience through the company’s successful acquisition in 2011. Most recently, he led a start-up ultrasound technology company. Jeff earned a B.S. in Life Sciences from the University of Illinois at Urbana-Champaign and M.S. and Ph.D. degrees from Northwestern University.
“Jeff served as a consultant to Imbed in the company’s early days on SBIR grants and quality management system. He is an excellent scientist and brings rigor of managing product development in start-up environment. I am happy to welcome him back in a more formal role,” said Ankit Agarwal, Imbed’s President and CEO.
“I’ve known Ankit for several years now and have followed Imbed’s progress with great interest. I am very happy to have the opportunity to again contribute to this team and assist in bringing a much-need wound care device to clinical users,” said Dalsin.
About Imbed Biosciences, Inc.
Imbed Biosciences is a privately held medical device company developing next-generation medical devices for the management of burns, chronic ulcers, gastro-intestinal defects, and tissue repair. Company has a portfolio of products in development based on its patented polymeric Microfilm™ platform that present bioactive molecules on tissue surfaces to manage wound infections, biofilms, and local pain and support wound healing. Imbed is backed by venture capital group WISC Partners based in Madison, WI. Company has also received research grants from National Institutes of Health and National Science Foundation. For more information, visit www.www.imbedbio.com and follow facebook.com/imbedbio and @imbedbio on twitter.
Ankit Agarwal, CEO, Imbed Biosciences Inc.